Ledger.Open graph →
SEC Form D · filed July 14, 2021

Kriya Therapeutics, Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
REDWOOD CITY, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Saira Ramasastry · Redwood City, CADirectorDana Johnson · Redwood City, CAExecJames Momtazee · Redwood City, CADirectorRoger Jeffs · Redwood City, CADirectorShankar Ramaswamy · Redwood City, CAExec · DirectorKeith Manchester · Redwood City, CADirectorIlan Oren · Redwood City, CADirectorC.R. Sincock · Redwood City, CADirectorBrennan P. Berry · Midland, TXDirectorPaul G. Lukeman · Columbus, OHExec · DirectorFlowtrack Protocol Fund GP LLC · Miami, FLDirectorErp 1031 LLC · Midland, TXExecWarren Rickards · Miami, FLDirectorFlowtrack Fund Management Company LLC · Miami, FLDirectorBen Somers · Miami, FLDirectorRamon Pitter · Miami, FLDirectorDaniel Chen · Troy, MIExecStephen Wilhite · Quincy, MADirectorRyan Letourneau · Quincy, MADirectorMatthieu Boujonnier · Quincy, MADirectorJeff D. Brown · Wheaton, ILDirectorStephen J. Elia · New York, NYDirectorMatt Posard · Menlo Park, CAExecSteven E. Decillis Ii · New York, NYDirectorJohn F. Cozzi · New York, NYExec · DirectorDaniel Chen · Troy, MIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗